ZENTRUDO Trademark

Trademark Overview

On Tuesday, July 14, 2020, a trademark application was filed for ZENTRUDO with the United States Patent and Trademark Office. The USPTO has given the ZENTRUDO trademark a serial number of 90051853. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 26, 2024. This trademark is owned by Teva Pharmaceuticals International GmbH. The ZENTRUDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, autoimmune, neurological, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations for use in hematology
zentrudo

General Information

Serial Number90051853
Word MarkZENTRUDO
Filing DateTuesday, July 14, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, autoimmune, neurological, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations for use in hematology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJona 8645
CH
Party NameTeva Pharmaceuticals International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJona 8645
CH

Trademark Events

Event DateEvent Description
Monday, February 26, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 26, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2023SOU EXTENSION 5 GRANTED
Wednesday, July 26, 2023SOU EXTENSION 5 FILED
Wednesday, July 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2023SOU EXTENSION 4 GRANTED
Thursday, January 26, 2023SOU EXTENSION 4 FILED
Thursday, April 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 28, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, February 28, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, February 28, 2023PETITION TO REVIVE-GRANTED
Tuesday, February 28, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, February 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 26, 2022SOU EXTENSION 3 GRANTED
Tuesday, July 26, 2022SOU EXTENSION 3 FILED
Tuesday, July 26, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 25, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 25, 2022SOU EXTENSION 2 FILED
Tuesday, January 25, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2021SOU EXTENSION 1 GRANTED
Monday, May 17, 2021SOU EXTENSION 1 FILED
Monday, May 17, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 26, 2020ASSIGNED TO EXAMINER
Wednesday, August 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 17, 2020NEW APPLICATION ENTERED

Related Keywords

zentrudo preparations pharmaceutical treatment urogenital urological respiratory viral disorders hematology pain